X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Camlin Fine Sciences Ltd.
BSE CODE: 532834   |   NSE CODE: CAMLINFINE   |   ISIN CODE : INE052I01032   |   22-Dec-2025 Hrs IST
BSE NSE
Rs. 156.50
0.95 ( 0.61% )
 
Prev Close ( Rs.)
155.55
Open ( Rs.)
155.60
 
High ( Rs.)
158.75
Low ( Rs.)
155.35
 
Volume
17661
Week Avg.Volume
11645
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 156.03
0.51 ( 0.33% )
 
Prev Close ( Rs.)
155.52
Open ( Rs.)
157.06
 
High ( Rs.)
158.98
Low ( Rs.)
155.18
 
Volume
232077
Week Avg.Volume
288160
 
52 WK High-Low Range(Rs.)
113.24
333.3
Source DateBoard Meeting DateDetails
03-Nov-2025 10-Nov-2025 Quarterly Results
24-Sep-2025 29-Sep-2025 Preferential Issue of shares & Inter-alia, to consider and if thought fit, to approve the proposal for issuance of equity shares of the Company by way of preferential allotment on a private placement basis towards consideration payable for acquisition of majority equity stake in Vinpai pursuant to a share swap arrangement ( Share Swap ), in accordance with the provisions of the Companies Act, 2013, and rules made thereunder, as amended, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and such other applicable laws, and subject to statutory / regulatory approval as may be required and approval of shareholders of the Company. The Board would also consider convening an postal ballot process to seek approval of the shareholders of the Company in respect of the aforesaid proposal of preferential issue for Share Swap, as required.
01-Aug-2025 08-Aug-2025 Quarterly Results
14-May-2025 23-May-2025 Audited Results
06-Feb-2025 14-Feb-2025 Quarterly Results
31-Dec-2024 02-Jan-2025 Inter alia, to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue
18-Nov-2024 22-Nov-2024 Right Issue of Equity Shares & Inter alia to consider and approve (subject to regulatory/ statutory and other approvals, as may be required) the following: 1. The revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and 2. Issue of any debt securities of the Company
28-Oct-2024 11-Nov-2024 Quarterly Results
05-Sep-2024 10-Sep-2024 Increase in Authorised Capital & Right Issue of Equity Shares
05-Aug-2024 12-Aug-2024 Quarterly Results
Page 1 of 9
PREV || NEXT